| For: | Lopes MA, Oliveira ECS, Quaglio AEV, Santos A, Imbrizi M, Mendes LER, Beraldo RF, Baima JP, Spiller AL, Magro DO, Sassaki LY. From gut to liver: Exploring the relationship between inflammatory bowel disease and metabolic dysfunction-associated steatotic liver disease. World J Hepatol 2025; 17(9): 109035 [PMID: 41024868 DOI: 10.4254/wjh.v17.i9.109035] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i9/109035.htm |
| Number | Citing Articles |
| 1 |
Ali Abdulla, Ayan M. Sheikhnoor, Kevin Ferrao, Lucy I. Stiles, Kosha J. Mehta. Bidirectional interplay between gut and liver in inflammatory bowel disease and hepatobiliary conditions. Clinical and Experimental Medicine 2026; doi: 10.1007/s10238-026-02102-w
|
| 2 |
Fotios Fousekis, Afroditi Lamprou, Maria Saridi, Ioanna Nefeli Mastorogianni, Konstantinos Mpakogiannis, Georgios D. Lianos, Konstantinos H. Katsanos. Metabolic Disorders and Inflammatory Bowel Diseases: Unraveling Shared Pathways and Clinical Interactions. Metabolites 2026; 16(3): 181 doi: 10.3390/metabo16030181
|
| 3 |
Cheng Chang, Xiaolan Hu, Qimao Hu, Anrui Zheng. The role of ulcerative colitis-associated genes in the prognosis, immune cell infiltration, and immunotherapy efficacy of hepatocellular carcinoma. European Journal of Medical Research 2026; doi: 10.1186/s40001-026-04283-2
|
